VIVO-AQ Clinical Monograph & Batch COA
Certified DCGI Formulation Literature (PDF)
VIVO-AQ
Diclofenac Sodium 1% w/w
VIVO-AQ (Diclofenac Sodium 1% w/w) is manufactured under strict WHO-GMP compliance for maximum bioavailability and therapeutic efficacy.
Clinical Pharmacology & Therapeutic Profile
Comprehensive therapeutic guidelines for medical practitioners and institutional procurement
Therapeutic Indications
Mechanism of Action (MOA)
The active pharmacological principles in VIVO-AQ deliver targeted therapeutic action through standardized systemic bioavailability and verified pharmacodynamics.
As directed by the registered medical practitioner. Strictly adhere to full course duration.
Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.
Store between 2°C to 8°C or below 25°C as indicated on label. Protect from light.
WHO-GMP Certified Purity
Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.
Alu-Alu Moisture Barrier
Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.
Exclusive District Monopoly
Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.
Technical Product Specifications
Active Medical Composition
VIVO-AQ features Diclofenac Sodium 1% w/w prepared to high pharmaceutical purity standards.
*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.
Customer & Clinical Reviews
Real feedback from registered physicians, stockists, PCD franchise partners, and verified buyers.
Based on 2 verified reviews
Exceptional clinical efficacy and stability for VIVO-AQ
We have been prescribing and distributing VIVO-AQ across our medical network. The therapeutic response in patients is rapid with virtually zero tolerance complaints. The Alu-Alu blister packaging provides superior moisture protection even in high-humidity monsoon conditions. Highly recommended for standard clinical protocols.
Consistent batch purity & fast patient recovery
Batch-to-batch analytical purity of VIVO-AQ is consistently high with verifiable COA documentation. Doctors in our territory report high patient compliance and fast symptomatic relief. Sygnus Biotech maintains excellent supply turnaround times and strict WHO-GMP manufacturing standards.
Questions Regarding VIVO-AQ
What is the therapeutic indication and composition of VIVO-AQ?
VIVO-AQ contains Diclofenac Sodium 1% w/w indicated for Indicated for therapeutic management within specified clinical indications under qualified physician guidance. as formulated by Sygnus Biotech.
What packaging presentations are available for VIVO-AQ?
VIVO-AQ is supplied in tamper-evident Single Dose Sterile Vial with Ampoule & WFI, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.
Is monopoly PCD franchise territory available for VIVO-AQ?
Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for VIVO-AQ along with promotional visual aids, product cards, and marketing support.
What is the regulatory schedule and minimum order quantity (MOQ)?
VIVO-AQ is categorized as Schedule H1 Prescription Drug with an introductory PCD franchise MOQ of 100 units per batch.
Related Formulations in Injection
View all Injection →
SBCEF-S 375MG
Ceftriaxone Sodium 250mg + Sulbactam 125mg Injection
